Log In
BCIQ
Print this Print this
 

Insulin tregopil (formerly IN-105)

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionOral conjugated insulin analog
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/19/2012

Undisclosed

0

Undisclosed

Get a free BioCentury trial today